Last reviewed · How we verify

Quimethazin — Competitive Intelligence Brief

Quimethazin (QUINETHAZONE) competitive landscape: 4 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: quinethazone. Area: Cardiovascular.

marketed quinethazone Solute carrier family 12 member 3 Cardiovascular Small molecule Live · refreshed every 30 min

Target snapshot

Quimethazin (QUINETHAZONE).

Comparator set (4 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Quimethazin TARGET QUINETHAZONE marketed quinethazone Solute carrier family 12 member 3 1963-01-01
Enduron methylclothiazide marketed Thiazide Diuretic Solute carrier family 12 member 3 1960-01-01
Corzide BENDROFLUMETHIAZIDE marketed Thiazide Diuretic Solute carrier family 12 member 3 1959-01-01
Saluron HYDROFLUMETHIAZIDE Shire Llc marketed Thiazide Diuretic Solute carrier family 12 member 3 1959-01-01
Diuril CHLOROTHIAZIDE Salix Pharms marketed Thiazide Diuretic Solute carrier family 12 member 3 1958-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (quinethazone class)

  1. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Quimethazin — Competitive Intelligence Brief. https://druglandscape.com/ci/quinethazone. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: